MetaCap

Editas Medicine Quarterly Balance Sheet

NASDAQ: EDITHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.64-0.07 (-4.09%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Editas Medicine financial position

As of Sep 30, 2026, Editas Medicine reported total assets of $219.4 million, up 8.8% from a year earlier against total liabilities of $134.9 million. Shareholders' equity stood at $84.5 million, or 38.5% of assets. The company held $93.2 million in cash and equivalents against $56.8 million of debt, a net cash position of $36.3 million.

The current ratio (current assets divided by current liabilities) was 2.82, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.67.

Summary generated from market data by MetaCap's automated system. Methodology

Editas Medicine balance sheet (quarterly)

Editas Medicine quarterly balance sheet
Quarter (USD)Q3 20262026-09-30Q2 20262026-06-30Q1 20262026-03-31Q4 20252025-12-31Q3 20252025-09-30Q2 20252025-06-30Q1 20252025-03-31Q4 20242024-12-31Q3 20242024-09-30Q2 20242024-06-30Q1 20242024-03-31Q4 20232023-12-31
Cash & Equivalents93.17M181.81M123.65M146.65M165.65M138.54M138.69M131.54M95.83M64.44M69.23M123.65M
Short-Term Investments97.03M29.83M—0039.96M82.27M138.37M169.26M214.67M226.94M199.46M
Receivables7.73M2.73M2.59M15.18M8.13M588.00K510.00K16.27M126.00K244.00K245.00K10.19M
Total Current Assets201.97M218.07M128.07M163.90M176.89M182.80M224.84M289.31M271.14M286.35M305.56M340.83M
Property, Plant & Equipment2.19M2.57M2.88M3.54M4.29M4.58M8.18M14.50M15.42M14.16M13.26M12.03M
Long-Term Investments———————0039.20M80.61M104.02M
Total Assets219.41M237.36M149.34M186.53M201.75M210.58M263.65M341.59M327.57M384.80M440.35M499.15M
Accounts Payable6.82M4.74M4.33M2.60M3.16M6.72M5.46M5.49M12.49M13.77M7.97M8.27M
Short-Term Debt7.50M7.50M7.50M5.00M5.00M5.00M5.00M5.00M———0
Total Current Liabilities71.58M68.43M39.78M46.25M61.77M65.94M73.11M77.22M72.35M74.31M66.49M63.22M
Long-Term Debt49.32M48.24M47.18M53.60M54.07M51.67M49.58M52.43M———0
Total Liabilities134.89M132.08M144.93M159.25M188.30M191.39M201.23M207.31M151.93M152.79M145.95M150.06M
Shareholders' Equity84.52M105.28M4.41M27.29M13.45M19.19M62.42M134.27M175.63M232.01M294.40M349.10M
Retained Earnings-1.70B-1.67B-1.65B-1.63B-1.62B-1.60B-1.54B-1.47B-1.42B-1.36B-1.29B-1.23B
Total Debt56.82M55.74M54.68M58.60M59.07M56.67M54.58M57.43M———0
Net Cash (Debt)133.38M155.91M68.97M88.04M106.58M121.83M166.38M212.48M265.09M279.11M296.17M323.11M
Shares Outstanding97.87M97.87M97.87M97.87M93.26M87.39M83.71M82.73M82.54M82.43M82.23M81.77M

This table shows 12 quarterly periods of Editas Medicine's balance sheet, from Q3 2026 back to Q4 2023, across 17 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow EDIT's reporting calendar. What is a balance sheet?

More financial data